BioSenic S.A. (BIOS) - Total Liabilities

Latest as of June 2025: €28.10 Million EUR ≈ $32.85 Million USD

Based on the latest financial reports, BioSenic S.A. (BIOS) has total liabilities worth €28.10 Million EUR (≈ $32.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BioSenic S.A. net asset momentum to track the company's year-over-year net asset growth rate.

BioSenic S.A. - Total Liabilities Trend (2011–2024)

This chart illustrates how BioSenic S.A.'s total liabilities have evolved over time, based on quarterly financial data. See BIOS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

BioSenic S.A. Competitors by Total Liabilities

The table below lists competitors of BioSenic S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
Kestrel Gold Inc V:KGC	Canada	CA$35.81K
Triangle Energy (Global) Ltd AU:TEG	Australia	AU$20.25 Million
Nuwellis Inc NASDAQ:NUWE	USA	$4.07 Million
Prosper Gold Corp. V:PGX	Canada	CA$200.32K
GOLCAP RESOURCES CORP F:2SO0	Germany	€1.84 Million
CQS Natural Resources Growth and Income plc LSE:CYN	UK	GBX9.70 Million
Usha Martin Education & Solutions Limited NSE:UMESLTD	India	Rs23.70 Million
Shirpur Gold Refinery Limited NSE:SHIRPUR-G	India	Rs7.39 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down BioSenic S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BioSenic S.A. stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	6.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioSenic S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioSenic S.A. (2011–2024)

The table below shows the annual total liabilities of BioSenic S.A. from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€31.55 Million ≈ $36.89 Million	-2.21%
2023-12-31	€32.26 Million ≈ $37.72 Million	+23.15%
2022-12-31	€26.20 Million ≈ $30.63 Million	-1.27%
2021-12-31	€26.54 Million ≈ $31.02 Million	+23.37%
2020-12-31	€21.51 Million ≈ $25.15 Million	+5.73%
2019-12-31	€20.34 Million ≈ $23.79 Million	-4.31%
2018-12-31	€21.26 Million ≈ $24.86 Million	-6.70%
2017-12-31	€22.79 Million ≈ $26.64 Million	-2.25%
2016-12-31	€23.32 Million ≈ $27.26 Million	+4.85%
2015-12-31	€22.24 Million ≈ $26.00 Million	-33.99%
2014-12-31	€33.69 Million ≈ $39.38 Million	+164.25%
2013-12-31	€12.75 Million ≈ $14.90 Million	+8.22%
2012-12-31	€11.78 Million ≈ $13.77 Million	+4.79%
2011-12-31	€11.24 Million ≈ $13.14 Million	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#30213 Global

#110 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66